Olutasidenib Uses, Dosage, Side Effects and more
Olutasidenib is under investigation in clinical trial NCT04013880 (ASTX727 and FT-2102 in Treating Idh1-mutated Recurrent/refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia).
| Trade Name | Olutasidenib |
| Generic | Olutasidenib |
| Olutasidenib Other Names | Olutasidenib |
| Type | |
| Formula | C18H15ClN4O2 |
| Weight | Average: 354.79 Monoisotopic: 354.0883534 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
